|
1
|
Dobruch J and Herr H: Should all patients
receive single chemotherapeutic agent instillation after bladder
tumour resection? BJU Int. 104:170–174. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kurth KH, Bouffioux C, Sylvester R, van
der Meijden AP, Oosterlinck W and Brausi M: Treatment of
superficial bladder tumors: achievements and needs. The EORTC
Genitourinary Group Eur Urol. 37(Suppl 3): 1–9. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y
and Namba M: A REIC gene shows down-regulation in human
immortalized cells and human tumor-derived cell lines. Biochem
Biophys Res Commun. 268:20–24. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tsuji T, Nozaki I, Miyazaki M, Sakaguchi
M, Pu H, Hamazaki Y, Iijima O and Namba M: Antiproliferative
activity of REIC/Dkk-3 and its significant down-regulation in
non-small-cell lung carcinomas. Biochem Biophys Res Commun.
289:257–263. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abarzua F, Sakaguchi M, Takaishi M, Nasu
Y, Kurose K, Ebara S, Miyazaki M, Namba M, Kumon H and Huh NH:
Adenovirus-mediated overexpression of REIC/Dkk-3 selectively
induces apoptosis in human prostate cancer cells through activation
of c-Jun-NH2-kinase. Cancer Res. 65:9617–9622. 2005. View Article : Google Scholar
|
|
6
|
Abarzua F, Sakaguchi M, Tanimoto R,
Sonegawa H, Li DW, Edamura K, Kobayashi T, Watanabe M, Kashiwakura
Y, Kaku H, Saika T, Nakamura K, Nasu Y, Kumon H and Huh NH: Heat
shock proteins play a crucial role in tumor-specific apoptosis by
REIC/Dkk-3. Int J Mol Med. 20:37–43. 2007.PubMed/NCBI
|
|
7
|
Edamura K, Nasu Y, Takaishi M, Kobayashi
T, Abarzua F, Sakaguchi M, Kashiwakura Y, Ebara S, Saika T,
Watanabe M, Huh NH and Kumon H: Adenovirus-mediated REIC/Dkk-3 gene
transfer inhibits tumor growth and metastasis in an orthotopic
prostate cancer model. Cancer Gene Ther. 14:765–772. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Watanabe M, Kashiwakura Y, Huang P, Ochiai
K, Futami J, Li SA, Takaoka M, Nasu Y, Sakaguchi M, Huh NH and
Kumon H: Immunological aspects of REIC/Dkk-3 in monocyte
differentiation and tumor regression. Int J Oncol. 34:657–663.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kashiwakura Y, Ochiai K, Watanabe M,
Abarzua F, Sakaguchi M, Takaoka M, Tanimoto R, Nasu Y, Huh NH and
Kumon H: Down-regulation of inhibition of differentiation-1 via
activation of activating transcription factor 3 and Smad regulates
REIC/Dickkopf-3-induced apoptosis. Cancer Res. 68:8333–8341. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tanimoto R, Abarzua F, Sakaguchi M,
Takaishi M, Nasu Y, Kumon H and Huh NH: REIC/Dkk-3 as a potential
gene therapeutic agent against human testicular cancer. Int J Mol
Med. 19:363–368. 2007.PubMed/NCBI
|
|
11
|
Jin Y, Murata H, Sakaguchi M, Kataoka K,
Watanabe M, Nasu Y, Kumon H and Huh NH: Partial sensitization of
human bladder cancer cells to a gene-therapeutic adenovirus
carrying REIC/Dkk-3 by downregulation of BRPK/PINK1. Oncol Rep.
27:695–699. 2012.PubMed/NCBI
|
|
12
|
Zincke H, Utz DC, Taylor WF, Myers RP and
Leary FJ: Influence of thiotepa and doxorubicin instillation at
time of transurethral surgical treatment of bladder cancer on tumor
recurrence: a prospective randomized, double blind, controlled
trial. J Urol. 129:505–509. 1983.
|
|
13
|
Cole SP, Bhardwaj G, Gerlach JH, Mackie
JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM and
Deeley RG: Overexpression of a transporter gene in a
multidrug-resistant human lung cancer cell line. Science.
258:1650–1654. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gottesman MM and Pastan I: Biochemistry of
multidrug resistance mediated by the multidrug transporter. Annu
Rev Biochem. 62:385–427. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou J, Liu M, Aneja R, Chandra R, Lage H
and Joshi HC: Reversal of P-glycoprotein-mediated multidrug
resistance in cancer cells by the c-Jun NH2-terminal kinase. Cancer
Res. 66:445–452. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kimiya K, Naito S, Soejima T, Sakamoto N,
Kotoh S, Kumazawa J and Tsuruo T: Establishment and
characterization of doxorubicin-resistant human bladder cancer cell
line, KK47/ADM. J Urol. 148:441–445. 1992.PubMed/NCBI
|
|
17
|
Abarzua F, Kashiwakura Y, Takaoka M,
Watanabe M, Ochiai K, Sakaguchi M, Iwawaki T, Tanimoto R, Nasu Y,
Huh NH and Kumon H: An N-terminal 78 amino acid truncation of
REIC/Dkk-3 effectively induces apoptosis. Biochem Biophys Res
Commun. 375:614–618. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Belloc F, Dumain P, Boisseau MR,
Jalloustre C, Reiffers J, Bernard P and Lacombe F: A flow
cytometric method using Hoechst 33342 and propidium iodide for
simultaneous cell cycle analysis and apoptosis determination in
unfixed cells. Cytometry. 17:59–65. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Maciorowski Z, Delic J, Padoy E,
Klijanienko J, Dubray B, Cosset JM, Dumont J, Magdelénat H and
Vielh P: Comparative analysis of apoptosis measured by Hoechst and
flow cytometry in non-Hodgkin’s lymphomas. Cytometry. 32:44–50.
1998.PubMed/NCBI
|
|
20
|
Bennett BL, Sasaki DT, Murray BW, O’Leary
EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y,
Bhagwat SS, Manning AM and Anderson DW: SP600125, an
anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad
Sci USA. 98:13681–13686. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Harris AL and Neal DE: Bladder cancer -
field versus clonal origin. N Engl J Med. 326:759–761. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Oosterlinck W, Kurth KH, Schroder F,
Bultinck J, Hammond B and Sylvester R: A prospective European
Organization for Research and Treatment of Cancer Genitourinary
Group randomized trial comparing transurethral resection followed
by a single intravesical instillation of epirubicin or water in
single stage Ta, T1 papillary carcinoma of the bladder. J Urol.
149:749–752. 1993.
|
|
23
|
Solsona E, Iborra I, Ricos JV, Monros JL,
Casanova J and Dumont R: Effectiveness of a single immediate
mitomycin C instillation in patients with low risk superficial
bladder cancer: short and long-term follow-up. J Urol.
161:1120–1123. 1999. View Article : Google Scholar
|
|
24
|
Naito S, Sakamoto N, Kotoh S, Goto K,
Matsumoto T and Kumazawa J: Correlation between the expression of
P-glycoprotein and multidrug-resistant phenotype in transitional
cell carcinoma of the urinary tract. Eur Urol. 22:158–162.
1992.PubMed/NCBI
|
|
25
|
Sakaguchi M, Kataoka K, Abarzua F,
Tanimoto R, Watanabe M, Murata H, Than SS, Kurose K, Kashiwakura Y,
Ochiai K, Nasu Y, Kumon H and Huh NH: Overexpression of REIC/Dkk-3
in normal fibroblasts suppresses tumor growth via induction of
interleukin-7. J Biol Chem. 284:14236–14244. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kawasaki K, Watanabe M, Sakaguchi M,
Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH,
Kumon H and Date H: REIC/Dkk-3 overexpression downregulates
P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces
apoptosis in breast cancer. Cancer Gene Ther. 16:65–72. 2009.
View Article : Google Scholar : PubMed/NCBI
|
